Table 1.
Relative transduction efficiency (%) | ||
---|---|---|
VSV-G | No block | 100 |
cRGD peptide | 96 | |
cRAD peptide | 92 | |
Anti-integrins | 101 | |
Isotype control | 98 | |
cRGD-nVSV-G | No block | 100 |
cRGD peptide | 40 | |
cRAD peptide | 97 | |
Anti-integrins | 70 | |
Isotype control | 96 |
The 1×105 Hela cells were preincubated with cRGD (1 mg/ml), cRAD (1mg/ml), anti-integrins antibodies (20 ug/ml), and isotype control (40 ug/ml) for 30 min, then transduced with equal amount of VSV-G and cRGD-nVSV-G (p24=10 ng).